Israel’s ViAqua (advisor Prof Avi Schroeder) develops a particle-based method for orally administering antiviral medication to combat deadly viruses in shrimp – a global market worth some $18 billion. ViAqua has just received investment from Singapore’s VisVires New Protein Master Fund.
https://www.calcalistech.com/ctech/articles/0,7340,L-3752021,00.html